GC Biotech specializes in the research and development of vaccine adjuvants, providing global clients with integrated products, services, and technological solutions. Our scope encompasses everything from raw materials and adjuvant molecules to delivery systems, spanning from discovery to pre-clinical and clinical research stages.

Our Goals

• Build a more cost-effective capacity for adjuvant and formulation production
• Become a reliable partner for researchers in human and veterinary vaccines
• Design and develop vaccine adjuvant systems tailored to various needs

Our integrated and open-access platform helps reduce R&D costs and accelerate the global delivery of new vaccines. Through technology transfer, technical consultation, and partnership development, we assist our customers in delivering affordable and innovative vaccines to combat various infectious diseases, allergic diseases, and cancers.

Technical Support & Solutions

We offer formulation development and manufacturing services, including pre-formulation studies, formulation design and optimization, process scale-up, stability studies, analytical method development, and analytical method validation.

• Pre-formulation studies
• Formulation design and optimization
• Process scale-up
• Stability studies
• Analytical method development
• Analytical method validation

Immune Modulators and Customized Adjuvant Molecules

• Saponins derived from Quillaja Saponaria Molina, including QS-21, QS-7, VQ-SAP, and customized saponins
• TLR4 Agonists such as 3D-MPLA derived from Salmonella Minnesota, strain R595, and customized TLR4 agonists
• Multiple options for discovery scales, purification levels, and modification methods of adjuvant molecules that meet GLP/GMP standards

Delivery Systems and Formulations

• Provide delivery systems for human and veterinary vaccine research and development that meet GLP/GMP standards
• Offer three different delivery systems and support custom formulations with immune modulators
• Offer a variety of adjuvant formulations to suit different vaccine antigens

Development and Manufacturing

• Conduct production and purification of adjuvant raw materials in accordance with ISO9001 standards
• Use high-performance liquid chromatography (HPLC) technology to produce and purify adjuvant molecules under cGMP standards
• Employ cutting-edge technologies to produce adjuvant systems under cGMP standards
• Provide material and data packages for research and product development